Editor's Note

• Jurisdiction: United States,Federal
• Citation: Vol. 27 No. 1
• Publication year: 2018
• topic: Antitrust and Competition,Intellectual Property,Health Law

EDITOR'S NOTE

Anna Fabish

O'Melveny & Myers LLP

Los Angeles, CA

Competition and privacy law issues in the healthcare and pharmaceutical industries are constantly making headlines—and for good reason. The intersection of healthcare/ pharmaceutical regulation and policy with competition, privacy, and intellectual property law is generating a vast universe of intriguing questions. And if the amount of litigation and enforcement efforts in the United States and abroad is any indication, that universe is only growing. There is simply no escaping that hospitals and pharmacies are the foremost frontier for competition and privacy law issues today.

It is therefore with great excitement that I present the Winter 2017-18 issue of Competition, focusing solely on this timely and important topic. In preparing the issue, I had the pleasure of working with a tremendous group of authors, comprised of private practitioners, enforcers, academics, and economists. I extend my deepest thanks to them for their hard work and thoughtful commentary. The range of our authors' backgrounds adds a dimension to the analysis presented in this issue of Competition that I find both fascinating and helpful as I grapple with many of these topics in my own practice. I hope these articles will be of similar interest and usefulness to you. Thank you also to the team of editors for their insight and assistance in finalizing these articles.

The collection of articles in our Winter 2017-2018 edition examines a sampling of various legal, economic, and policy questions presented by the healthcare and pharmaceutical sectors today:

First, the issue offers several discussions of...